• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives N-alkylindoles

1-Methyl-1H-Indole-7-carboxylic acid ethyl ester (CAS No. 126691-26-7): A Comprehensive Overview in Modern Chemical Biology and Medicinal Chemistry

The compound 1-methyl-1H-indole-7-carboxylic acid ethyl ester, identified by its CAS number 126691-26-7, represents a significant molecule in the realm of chemical biology and medicinal chemistry. This heterocyclic derivative, featuring a methyl-substituted indole core and an ethyl ester functionality at the 7-position, has garnered attention due to its structural versatility and potential biological activities. The indole scaffold, a prominent motif in natural products and bioactive molecules, underpins its relevance in drug discovery and therapeutic development.

Recent advancements in the field have highlighted the compound's utility as a key intermediate in synthesizing novel pharmacophores. The ethyl ester group not only provides a handle for further chemical modifications but also influences the molecule's solubility and metabolic stability, critical factors in drug design. Researchers have leveraged this compound to develop derivatives with enhanced binding affinity and selectivity for target enzymes and receptors.

One of the most compelling aspects of 1-methyl-1H-indole-7-carboxylic acid ethyl ester is its role in exploring indole-based therapeutics. The indole ring is a cornerstone in medicinal chemistry, with numerous examples of indole derivatives exhibiting antimicrobial, anti-inflammatory, and anticancer properties. The introduction of the methyl group at the 1-position and the ester at the 7-position fine-tunes the electronic and steric properties of the molecule, enabling tailored interactions with biological targets.

In particular, studies have demonstrated its application in generating inhibitors of enzymes involved in metabolic pathways relevant to neurological disorders. The structural features of this compound allow for precise modulation of binding interactions, making it a valuable scaffold for designing molecules that can modulate neurotransmitter release or receptor activity. Such applications are particularly promising in the context of neurodegenerative diseases, where targeted interventions are crucial.

The synthesis of 1-methyl-1H-indole-7-carboxylic acid ethyl ester has been optimized through various methodologies, including multi-step organic transformations that highlight its synthetic accessibility. Recent reports have focused on greener synthetic routes, employing catalytic systems that minimize waste and improve yield. These developments align with broader trends in sustainable chemistry, ensuring that the production of this compound is both efficient and environmentally responsible.

Furthermore, computational studies have played a pivotal role in understanding the molecular interactions of 1-methyl-1H-indole-7-carboxylic acid ethyl ester. Molecular docking simulations have been used to predict binding modes with various biological targets, providing insights into how structural modifications can enhance potency and selectivity. These computational approaches complement experimental efforts, accelerates the discovery process by allowing rapid screening of virtual libraries.

The compound's potential extends beyond its use as an intermediate; it has been explored as a building block for more complex molecules with unique pharmacological profiles. By incorporating additional functional groups or appending different pharmacophores to its core structure, researchers can generate novel entities with tailored biological activities. This modular approach underscores the versatility of 1-methyl-1H-indole-7-carboxylic acid ethyl ester as a tool in medicinal chemistry.

Emerging research also highlights its role in developing probes for biochemical assays. The indole moiety serves as an excellent platform for designing fluorescent or luminescent probes that can track biological processes in real-time. Such probes are invaluable tools for understanding cellular mechanisms and have applications in both academic research and drug development pipelines.

Future directions for 1-methyl-1H-indole-7-carboxylic acid ethyl ester include exploring its derivatives as leads for clinical trials. The structural framework provides a robust foundation for generating compounds with improved pharmacokinetic profiles, such as enhanced bioavailability or prolonged half-life. Collaborative efforts between synthetic chemists and biologists will be essential to translate these findings into tangible therapeutic benefits.

In conclusion, 1-methyl-1H-indole-7-carboxylic acid ethyl ester (CAS No. 126691-26-7) stands out as a versatile and promising molecule in chemical biology and medicinal chemistry. Its unique structural features, coupled with its synthetic accessibility and potential biological activities, make it a valuable asset in drug discovery efforts. As research continues to uncover new applications for this compound, it is likely to remain at the forefront of therapeutic innovation.

• 108438-43-3(Methyl 1-methyl-1H-indole-3-carboxylate)
• 167479-21-2(methyl 1-methyl-1H-indole-7-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)